Body Mass Index and Its Change from Adolescence to Adulthood Are Closely Related to the Risk of Adult Metabolic Syndrome in China

Table 1

Baseline and follow-up clinical characteristics of subjects.

Items	Male (n = 50)		Female (n = 43)
	Baseline	Follow-up	Baseline	Follow-up
Age (year)	13.98 ± 1.45	19.98 ± 1.45	14.04 ± 1.31	20.04 ± 1.31
WC (cm)	73.45 ± 9.99	85.78 ± 10.10	70.61 ± 9.47	78 ± 9.27
WHR	0.82 ± 0.06	0.87 ± 0.06	0.78 ± 0.06	0.82 ± 0.14
BMI (kg/m^2)	22.53 ± 4.08	23.32 ± 3.69	21.6 ± 3.48	22.19 ± 4.09
SBP (mmHg)	122.16 ± 12.60	122.1 ± 10.99	116.91 ± 11.04	112.69 ± 11.04
DBP (mmHg)	71 ± 10.99	80.56 ± 7.72	73.72 ± 10.29	77.20 ± 8.38
TG (mmol/l)	1.03 (0.58, 1.28)	1.29 (0.79, 1.60)	1.01 (0.62, 1.22)	1.03 (0.67, 1.27)
HDL-C (mmol/L)	1.01 (0.84, 1.26)	0.94 (0.85, 1.03)	1.09 (0.94, 1.31)	1.08 (0.94, 1.18)
LDL-C (mmol/L)	3.36 (3.25, 3.46)	2.13 (1.78, 2.55)	3.46 (3.27, 3.54)	2.07 (1.72, 2.36)
FPG (mmol/L)	4.83 ± 0.65	4.14 ± 0.63	4.73 ± 0.51	4.21 ± 0.37
AST (μ/l)	19.26 ± 6.57	19.34 ± 12.72	16.60 ± 3.47	17.50 ± 8.25
ALT (μ/l)	14.86 ± 10.40	26.85 ± 24.33	11.02 ± 5.61	17.19 ± 14.30
Uric acid (μmol/l)	371.3 ± 85.68	394.25 ± 82.48	277.70 ± 81.70	284.78 ± 87.77
HbA1c (%)	5.43 (5.20, 5.62)	5.2 (5.50, 4.00)	5.44 (5.30, 5.60)	5.37 (5.17, 5.50)
HOMA-IR	4.48 ± 3.39	1.75 ± 0.60	4.28 ± 2.46	1.91 ± 0.78
Obesity (%)	22.00	28.00	23.26	44.17
MetS (%)	14.00	6.00	4.65	16.28

value <0.05 indicates statistical significance. BMI: body mass index; WC: waist circumference; WHR: waist-to-hip ratio; SBP: systolic blood pressure; DBP: diastolic blood pressure; TG: triglycerides; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; FPG: fasting plasma glucose; ALT: alanine transaminase; AST: aspartate transaminase; HOMA-IR: homoeostatic model assessment for insulin resistance.